| Keywords 3-1 * |
|
|
|
| 04 |
|
Chronic progressive diseases |
|
| 05 |
|
Circulatory failure・Circulatory disturbance |
|
| 06 |
|
Metabolic disorder・Degenerative disorder |
|
| 07 |
|
Transplantation pathology |
|
| 08 |
|
Intractable and rare diseases |
|
| 09 |
|
Congenital disorder・Developmental anomaly |
|
|
|
|
| 13 |
|
Intraoperative consultation |
|
| 14 |
|
Differential diagnosis |
|
| 15 |
|
Immunohistochemistry・Diagnostic molecular pathology |
|
| 16 |
|
Classification of Diseases |
|
| 17 |
|
Evaluation of treatment effects・Therapeutic strategies |
|
| 18 |
|
Epidemiology・Statistics |
|
| 19 |
|
Image analysis・AI・Digital pathology |
|
| 20 |
|
Information technology・Bioinformatics |
|
| 21 |
|
Education・Medical staff |
|
|
|
| 24 |
|
Chromosomal abnormality・Hereditary diseases |
|
|
| 26 |
|
Genetic risks・Environmental factors |
|
| 27 |
|
Genetic mutation・Carcinogenesis |
|
| 28 |
|
Gene expression・Epigenetics |
|
| 29 |
|
Signal transduction・Cell proliferation・Cell cycle |
|
| 30 |
|
Cell death・Cell damage・Senescence |
|
| 31 |
|
Invasion and metastasis |
|
| 32 |
|
Cancer microenvironment・Cancer stem cells |
|
| 33 |
|
Cancer cellular characteristics |
|
|
| 35 |
|
Diagnostic markers・Tumor markers・New therapies |
|
| 36 |
|
Cell biology・Molecular imaging |
|
| 37 |
|
Cell differentiation・Regenerative medicine |
|
| 38 |
|
Development and developmental abnormalities |
|
|
| 40 |
|
Autoimmunity・Autoinflammation |
|
| 41 |
|
Novel technology・Experimental technique |
|
|